Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

New ibrutinib combination regimen shows substantial benefits in relapsed chronic lymphocytic leukaemia

Prof Asher Chanan-Khan - Mayo Clinic, Jacksonville, USA
New ibrutinib combination regimen shows substantial benefits in relapsed chronic lymphocytic leukaemia ( Prof Asher Chanan-Khan - Mayo Clinic, Jacksonville, USA )
30 May 2015

Obinutuzumab doubles remission duration in patients with relapsed, indolent non-hodgkin lymphoma

Dr Laurie Helen Sehn - BC Cancer Agency, Vancouver, Canada
Obinutuzumab doubles remission duration in patients with relapsed, indolent non-hodgkin lymphoma ( Dr Laurie Helen Sehn - BC Cancer Agency, Vancouver, Canada )
30 May 2015

First-in-class targeted drug daratumumab shows promise in heavily treatment-resistant multiple myeloma

Dr Saad Zafar Usmani - Levine Cancer Institute, Charlotte, USA
First-in-class targeted drug daratumumab shows promise in heavily treatment-resistant multiple myeloma ( Dr Saad Zafar Usmani - Levine Cancer Institute, Charlotte, USA )
30 May 2015

Immunotherapy developments in lung, head and neck, liver and PD-1 repsonse prediction

Dr Lynn Schuchter - University of Pennsylvania, Philadelphia, USA
Immunotherapy developments in lung, head and neck, liver and PD-1 repsonse prediction ( Dr Lynn Schuchter - University of Pennsylvania, Philadelphia, USA )
29 May 2015

Pembrolizumab for head and neck cancer

Dr Tanguy Seiwert - University of Chicago, Chicago, USA
Pembrolizumab for head and neck cancer ( Dr Tanguy Seiwert - University of Chicago, Chicago, USA )
29 May 2015

Pembrolizumab shows promising activity against head and neck cancer

Dr Tanguy Seiwert - University of Chicago, Chicago, USA
Pembrolizumab shows promising activity against head and neck cancer ( Dr Tanguy Seiwert - University of Chicago, Chicago, USA )
29 May 2015

Nivolumab shows highly promising activity in advanced liver cancer in early-stage trial

Dr Anthony El-Khoueiry - University of Southern California Norris Comprehensive Cancer Center, Los Angeles, USA
Nivolumab shows highly promising activity in advanced liver cancer in early-stage trial ( Dr Anthony El-Khoueiry - University of Southern California Norris Comprehensive Cancer Center, Los Angeles, USA )
29 May 2015

Genomic marker predicts anti-PD-1 response in several cancers

Dr Dung Le - Johns Hopkins Kimmel Cancer Center, Baltimore, USA
Genomic marker predicts anti-PD-1 response in several cancers ( Dr Dung Le - Johns Hopkins Kimmel Cancer Center, Baltimore, USA )
29 May 2015

ecancermedicalscience editor's choice for May 2015

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience editor's choice for May 2015 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
26 May 2015

Prostate cancer and pharmacokinetics: Expert discussion

Prof Axel S. Merseburger and Prof Romano Danesi
Prostate cancer and pharmacokinetics: Expert discussion ( Prof Axel S. Merseburger and Prof Romano Danesi )
26 May 2015

Using the FALCON contouring platform to improve radiation oncologists' technique

Dr Sofia Rivera - Institut Gustave Roussy, Villejuif, France
Using the FALCON contouring platform to improve radiation oncologists' technique ( Dr Sofia Rivera - Institut Gustave Roussy, Villejuif, France )
20 May 2015

Developing technical improvements to bladder radiotherapy using online imaging

Dr Robert Huddart - Institute of Cancer Research, London, UK
Developing technical improvements to bladder radiotherapy using online imaging ( Dr Robert Huddart - Institute of Cancer Research, London, UK )
20 May 2015